Overview

Study of AK119 and AK 112 With or Without Chemotherapy for Colorectal Cancer Patients

Status:
Not yet recruiting
Trial end date:
2025-07-10
Target enrollment:
Participant gender:
Summary
This is a phase Ib/II clinical study on AK119 and AK112 combined with or without chemotherapy in advanced microsatellite stabilized (pMMR/MSS) colorectal cancer
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Akeso
Treatments:
Calcium
Fluorouracil
Irinotecan
Leucovorin
Levoleucovorin
Oxaliplatin